Cite
HARVARD Citation
Mizushima, D. et al. (n.d.). Tenofovir disoproxil fumarate co-administered with lopinavir/ritonavir is strongly associated with tubular damage and chronic kidney disease. Journal of infection and chemotherapy. 24 (7), pp. 549-554. [Online].